Form 4 for MRNA Moderna
Accepted 2025-05-01 00:00:00 ET · period of report 2025-04-30 · accession 0001127602-25-012936 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-01 | 2025-04-30 | MRNA | Hussain Abbas | Dir | M - OptEx | — | +892 | 892 | New | — |
| D | 2025-05-01 | 2025-04-30 | MRNA | Hussain Abbas | Dir | A - Grant | $0.00 | +16.2K | 16.2K | New | $0 |
| D | 2025-05-01 | 2025-04-30 | MRNA | Hussain Abbas | Dir | M - OptEx | $0.00 | -892 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-30 | M | A | 892 | — | 892 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2025-04-30 | A | A | 16,233 | $0.00 | 16,233 | D | — · — to — | 16,233 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) The shares subject to this restricted stock unit award will vest in full on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service. |
| 3 | Derivative | Restricted Stock Units | 2025-04-30 | M | D | 892 | $0.00 | 0 | D | — · — to — | 892 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) The shares subject to this restricted stock unit award vested in full on April 30, 2025. |